Literature DB >> 7964612

Biogenesis of the hepatitis B viral middle (M) surface protein in a human hepatoma cell line: demonstration of an alternative secretion pathway.

S Y Sheu1, S J Lo.   

Abstract

In the serum of hepatitis B virus (HBV)-infected patients, two different types of particles, a 42 nm virion and a 22 nm subviral particle, were identified. The envelope of both particles is composed of three proteins, the large (L), middle (M), and major/small (S) surface proteins but the ratio between these components varies in each. The M protein appears in a lesser amount than the S protein in both virion and subviral particles, although it is translated from the same subgenomic RNA, and this is due to its poor initiation context of translation. In addition, only the glycosylated form of M protein is secreted in contrast to both glycosylated and unglycosylated forms of L and S proteins that are secreted. To investigate the biogenesis of M protein, human hepatoma cells transfected with plasmids containing a mutated HBV DNA were used to produce a high amount of M protein. Electron microscopic observation revealed that despite a higher proportion of the M protein being found in the transfected cells, the secreted surface antigen particles possess similar size and density to 22 nm subviral particles. Detailed biochemical analyses showed the following. (1) The unglycosylated M protein was predominantly present in the microsomal fraction but not present in any other subcellular fractions. (2) The M protein formed 22-nm-like particles in the endoplasmic reticulum (ER) and was retained in the post-ER or pre-Golgi regions. (3) In addition to the complex glycosylated form of M protein, a high-mannose form of M protein could be secreted. (4) Normally, no unglycosylated M protein was secreted. However, glycosylation was not essential for M protein secretion since M protein deprived of glycosylation by tunicamycin treatment was detected in the medium. These findings suggest that (i) the M protein was probably translated and co-translocated into the ER and at least one site was glycosylated before leaving the ER resulting in no secretion of unglycosylated M protein, and (ii) the M protein had two secretion pathways, one through the conventional pathway and the other probably directly through the ER.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7964612     DOI: 10.1099/0022-1317-75-11-3031

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

Review 1.  Molecular mechanisms underlying HBsAg negativity in occult HBV infection.

Authors:  R A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-06-24       Impact factor: 3.267

2.  Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion.

Authors:  A Mehta; X Lu; T M Block; B S Blumberg; R A Dwek
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

3.  Mutational analysis of glycosylation, membrane translocation, and cell surface expression of the hepatitis E virus ORF2 protein.

Authors:  M Zafrullah; M H Ozdener; R Kumar; S K Panda; S Jameel
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

4.  Impairment of hepatitis B virus virion secretion by single-amino-acid substitutions in the small envelope protein and rescue by a novel glycosylation site.

Authors:  Kiyoaki Ito; Yanli Qin; Michael Guarnieri; Tamako Garcia; Karen Kwei; Masashi Mizokami; Jiming Zhang; Jisu Li; Jack R Wands; Shuping Tong
Journal:  J Virol       Date:  2010-09-29       Impact factor: 5.103

5.  Role for calnexin and N-linked glycosylation in the assembly and secretion of hepatitis B virus middle envelope protein particles.

Authors:  M Werr; R Prange
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

6.  The degradation pathway for the HBV envelope proteins involves proteolysis prior to degradation via the cytosolic proteasome.

Authors:  Yuanjie Liu; Tianlun Zhou; Ender Simsek; Timothy Block; Anand Mehta
Journal:  Virology       Date:  2007-08-23       Impact factor: 3.616

7.  Expression of hepatitis B virus surface antigens induces defective gonad phenotypes in Caenorhabditis elegans.

Authors:  Yi-Yin Chen; Li-Wei Lee; Wei-Ning Hong; Szecheng J Lo
Journal:  World J Virol       Date:  2017-02-12

8.  Cryo-EM structures of human hepatitis B and woodchuck hepatitis virus small spherical subviral particles.

Authors:  Haitao Liu; Xupeng Hong; Ji Xi; Stephan Menne; Jianming Hu; Joseph Che-Yen Wang
Journal:  Sci Adv       Date:  2022-08-05       Impact factor: 14.957

Review 9.  Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms.

Authors:  Joan Kha-Tu Ho; Beena Jeevan-Raj; Hans-Jürgen Netter
Journal:  Viruses       Date:  2020-01-21       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.